Journal
CHEMMEDCHEM
Volume 14, Issue 19, Pages 1717-1726Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/cmdc.201900430
Keywords
bioorganometallic chemistry; cancer; iron; lipid peroxidation; thioredoxin reductase
Categories
Funding
- University of Padova (Italy) [BIRD187299/18]
Ask authors/readers for more resources
The ferrocenyl diphenol complexes 1,1-bis(4 '-hydroxyphenyl)-2-ferrocenyl-but-1-ene (1) and 1,2-bis(4 '-hydroxyphenyl)-1-ferrocenyl-but-1-ene [(Z)-2], which differ by the relative position of the two phenolic substituents, display dramatically different antiproliferative activities on cancer cells (1 is far more cytotoxic than 2). In this study, our goal was to discover the origin of this difference by comparing their reactivity and biological behaviour. In terms of common behaviour, we found that 1 and 2 are both efficient inhibitors of thioredoxin reductase (TrxR) in vitro after oxidation by a horseradish peroxidase/H2O2 system. However, as 1 is only a moderate inhibitor of TrxR in MDA-MB-231 cells, TrxR is probably not the major target responsible for the cytotoxicity of 1. In terms of differences, we noted that 1 induced a significant redox imbalance characterised by lipid peroxidation and thiol oxidation, and a moderate decrease of the mitochondrial membrane potential in breast cancer cells, whereas 2 has almost no effect. These results underline the importance of the trans configuration in the ferrocenyl-double bond-phenol motif, which is present in 1 but is cis in (Z)-2.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available